3 Turnaround Candidates for 2018 You Should Consider Now

Beleaguered companies such as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and others could stand to finally see a turnaround in 2018.

| More on:

Everyone loves a comeback story.

The market is full of them, and it’s during this end-of-year frenzy, between turkey dinners with family, that investors look towards next year and determine if some former greats could turn around.

Here are a few options to consider moving into 2018.

There’s no better stock that comes to mind when thinking of “epic collapse” than Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). The former darling of the market once had a market cap that exceeded some of Canada’s big banks before tumbling over 90% two years ago.

There are multiple reasons for that epic collapse, but a big one was that Valeant had a flawed business model that was overly reliant on cheap debt. When the stock finally tanked, Valeant was left with a broken business model, over US$30 billion in debt, and a stock price that left investors shaking their heads in disbelief.

Why is Valeant a good option now? Valeant’s new management team, headed by CEO Joseph Papa has not only begun to clean up the mess left by others, but it’s using a proper business model that is not entirely fueled on cheap loans. The company has also aggressively focused on debt reduction, selling non-core assets to pay down the mountain of debt.

Valeant is on track to finish 2017 on an impressive run with a stock price that is up year to date by 40%.

Cameco Corp. (TSX:CCO)(NYSE:CCJ) is another interesting turnaround target that is beginning to gain steam. Cameco is one of the largest uranium miners in the world, providing fuel for nuclear power plants.

The problem with Cameco is that when the Fukushima reactor in Japan was damaged following an earthquake-induced tsunami in 2011, world demand for uranium effectively dried up. This left Cameco and other uranium miners extracting uranium (for a significant cost) that nobody was buying. As the price continued to drop, and supplies continued to increase, a glut was formed that kept prices low, which was, thankfully, not entirely felt by Cameco due to the nature of long-term uranium purchase agreements.

There are two reasons to be optimistic about Cameco in 2018. First, Cameco and other leading uranium miners have announced a series of significant production cuts recently that will clear the supply glut and hopefully see prices begin to rise. The second reason has to do with demand, which is steadily growing thanks to a flurry of new construction and infrastructure development across the developing nations of Asia.

BlackBerry Ltd. (TSX:BB)(NYSE:BB) is another perennial turnaround candidate, which is arguably in the latter phases of its transformation. The company once had the leading market share of smartphones around the world, at least until both Android and iOS gobbled up that market share and reduced BlackBerry’s usage to little more than a rounding error.

Today, the company has little in common with its former self apart from a strong desire and industry-leading knowledge on security. BlackBerry no longer makes devices itself; rather, it licenses third parties to manufacture and market the devices.

BlackBerry’s real potential in 2018 and beyond lies in another area: automation. The company’s IoT asset-tracking solution holds promise, and the brain behind BlackBerry’s failed proprietary BB10 platform, QNX, is a key component to the future of autonomous driving; it’s already installed in over 60 million vehicles worldwide.

Year to date, BlackBerry has soared nearly 60%, and 2018 looks to be even more promising, as the company has finally returned to profitability.

Fool contributor Demetris Afxentiou has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of BlackBerry and Valeant Pharmaceuticals. BlackBerry is a recommendation of Stock Advisor Canada.

More on Tech Stocks

rising arrow with flames
Tech Stocks

1 Canadian Stock Supercharged to Surge in 2026

VitalHub crossed $100 million in revenue in 2025 and is building AI tools customers are already paying for. Here is…

Read more »

A person's hand cupped open with a hologram of an AI chatbot above saying Hi, can I help you
Tech Stocks

What the TFSA Fine Print Says About Holding U.S. Stocks

The TFSA protects Canadian gains from tax, but U.S. dividend stocks come with a 15% dividend withholding tax twist most…

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

3 Canadian Stocks That Could Thrive Even if the Economy Slows

If the TSX hits a softer patch, these three stocks stand out for durable demand, long-cycle work, or exposure to…

Read more »

Canada national flag waving in wind on clear day
Tech Stocks

1 Canadian Stock to Buy Before the Bank of Canada Speaks

BlackBerry is suddenly looking like a real pre-Bank of Canada play, with sticky government and auto customers, plus a turnaround…

Read more »

child looks at variety of flavors at ice cream store
Tech Stocks

What is One of the Best Tech Stocks to Own for the Next Decade?

Constellation Software (TSX:CSU) stock could be one of the best Canadian tech stocks to buy and hold for long term…

Read more »

Woman checking her computer and holding coffee cup
Tech Stocks

Billionaires Are Selling Amazon Stock and Betting on This TSX Stock

Billionaires are trimming Amazon stock and shifting attention to this TSX growth stock that’s gaining momentum.

Read more »

young adult uses credit card to shop online
Tech Stocks

Shopify Just Moved: 2 Canadian Tech Stocks to Buy Next

Shopify’s surge has put Canadian tech back in focus, but OpenText and Lightspeed look like two “next up” ideas with…

Read more »

chip glows with a blue AI
Tech Stocks

2 TSX Stocks That Could Give Your TFSA Returns a Meaningful Boost

Unlock the potential of your TFSA and discover how to maximize growth with strong investments and timely contributions.

Read more »